OTC: LBTSF - Almirall, S.A.

Rentabilität für sechs Monate: -5.26%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Almirall, S.A.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally.

weitere details
The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.08
Дивиденд ао 0.1915
Сайт https://www.almirall.com
Цена ао 9.01
Preisänderung pro Tag: 0% (9.01)
Preisänderung pro Woche: 0% (9.01)
Preisänderung pro Monat: -1.78% (9.173)
Preisänderung über 3 Monate: -1.78% (9.173)
Preisänderung über sechs Monate: -5.26% (9.51)
Preisänderung pro Jahr: -5.26% (9.51)
Preisänderung über 3 Jahre: 0% (9.01)
Preisänderung über 5 Jahre: 0% (9.01)
Preisänderung über 10 Jahre: 0% (9.01)
Preisänderung seit Jahresbeginn: -1.78% (9.173)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 1.81 8
P/BV 1.23 9
P/E 384.08 1
EV/EBITDA 9.79 8
Gesamt: 5.88

Effizienz

Name Bedeutung Grad
ROA, % -1.79 0
ROE, % -2.91 0
Gesamt: 1.17

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.7143 7.14
Gesamt: 3.25

Pflicht

Name Bedeutung Grad
Debt/EBITDA 1.98 7
Gesamt: 9.4

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 13.56 2
Rentabilität Ebitda, % -56.04 0
Rentabilität EPS, % -137.83 0
Gesamt: 0.4
Weitere Details

Institutionen Volumen Aktie, %
Hartford International Value Fund 1491055 0.82
Vanguard International Stock Index-Total Intl Stock Indx 1169408 0.64
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 675345 0.37
Vanguard Whitehall Fds-Vanguard Advice Select Global Value Fd 665229 0.37
DFA Continental Small Company Series 461737 0.25
iShares Core MSCI EAFE ETF 448261 0.25
Old Westbury Small & Mid Cap Strategies Fund 328618 0.18
iShares MSCI EAFE Small Cap ETF 311168 0.17
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 290960 0.16
DFA International Core Equity Portfolio 263398 0.15



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Carlos Gallardo Piqué CEO, President, Member of Management Board & Chairman of the Board 53.55k 1972 (53 Jahr)
Mr. Michael McClellan CFO & Member of Management Board N/A 1972 (53 Jahr)
Mr. Eloi Crespo Cervera Chief Industrial Operations Officer & Member of Management Board N/A
Mr. Esteve Conesa Panicot Chief People & Culture Officer and Member of Management Board N/A
Dr. Volker Koscielny Chief Medical Officer & Member of Management Board N/A
Dr. Karl Ziegelbauer Chief Scientific Officer & Member of Management Board N/A
Mr. Paolo Cionini Chief Commercial Officer Europe & International and Member of Management Board N/A
Ms. Isabel Cristina Gomes Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board N/A
Ms. Mercedes Diz Lopez Chief Marketing Officer & Member of Management Board N/A
Mr. Pablo Divasson del Fraile Senior Director of Investor Relations N/A

Adresse: Spain, Barcelona, Ronda General Mitre. 151 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.almirall.com